Completely AI-generated Novel Antibody

At immunitoAI™ we discover novel Antibody Therapeutics with pre-defined drug properties, entirely using AI. The AI-platform is built to be capable of generating de novo antibody and antibody fragments against any epitope and does not depend upon a biological source, animal or human, for the lead molecule. The generated antibodies are screened for drug-properties at the in-silico (computational) stage and only those antibodies that are fit to be drugs are taken to the in-house biological lab for experimental validation.

Read more on our blog.

Join us in our journey of making Antibody Therapy the norm.

What's New?

Investors & Supporters

 Lead investor

 Lead investor

Investor & Incubator

Grant-in-aid by

Grant-in-aid by

 Winner, healthcare category 

AI Open Innovation Day 2024 

Selected for

Selected for

Contact Us

Send us an Email:

Meet us:

Office: 2nd Floor, 879, NTI Layout,  2nd Phase, Rajeev Gandhi Nagar, Kodigehalli, Railway  Parallel Road, Bengaluru, Karnataka, India 560097

Lab: Centre for Cellular and Molecular Platforms (C-CAMP), NCBS-TIFR, GKVK Post, Bellary Rd, Bengaluru, Karnataka, India 560065